Clinical Efficacy of the Human Tyrosinase Inhibitor Thiamidol (isobutylamido thiazolyl resorcinol) in Melasma. (2025). SKIN The Journal of Cutaneous Medicine, 9(2), s544. https://doi.org/10.25251/skin.10.supp.544